Inhibitors of glucose metabolism for use in the treatment of Birt-Hogg-Dubé syndrome

摘要

A composition comprises an inhibitor of glucose metabolism for use in the treatment of Birt-Hogg-Dube syndrome. The inhibitor of glucose metabolism may be a glycolytic inhibitor, such as 2-deoxy-D-glucose. Alternatively, the inhibitor may be an inhibitor of lactate dehydrogenase in pyruvate metabolism, such as oxamate.